Results 251 to 260 of about 1,122,610 (333)

Unique analgesic properties of a chimeric peptide, ESP7, which possesses opioid and substance P moieties

, 1999
Stacy E. Foran, Iwona Maszczyńska, Andrzej W. Lipkowski, Daniel B. Carr, Richard M. Kream   +4 more
openalex   +1 more source

μ-Opioid Receptor Dynamics in the Parameningeal Tissue During Migraine Attacks. [PDF]

Ann Neurol
Kim DJ, Lim M, Nascimento TD, Porreca F, Koeppe RA, Hadjikhani N, DaSilva AF.   +6 more
europepmc   +1 more source

Disrupted circadian rhythms and opioid-mediated adverse effects: Bidirectional relationship and putative mechanisms. [PDF]

J Neuroendocrinol
Mehranfard N, Ghasemi M, Saboory E.
europepmc   +1 more source

Acute Postural Effects of Spinal Cord Injury: Dual Neural Opioid and Endocrine Non-Opioid Mechanism. [PDF]

Cells
Watanabe H, Lavrov I, Hallberg M, Schouenborg J, Zhang M, Bakalkin G.   +5 more
europepmc   +1 more source

Functional significance of opioid receptor homomers and heteromers. [PDF]

Nat Commun
Ferré S, Ciruela F, Pardo L.
europepmc   +1 more source

Review of the potential health impact of ß-casomorphins and related peptides: Report of the DATEX Working Group on ß-casomorphins [PDF]

FitzGerald, R.J., Korhonen, H.J.T., Livesey, C.T., Noni, I., De, Roux, Y., Le, Thorsdottir, I., Tomé, D., Witkamp, R.F.   +7 more
core  

Single-molecule characterization of opioid receptor heterodimers reveals soluble µ-δ dimer blocker peptide alleviates morphine tolerance. [PDF]

Nat Commun
Zhou P, Kasai RS, Fujita W, Tsunoyama TA, Neyama H, Ueda H, Yokoyama T, Sakamoto M, Pigolotti S, Fujiwara TK, Kusumi A.   +10 more
europepmc   +1 more source

Psychosis-like symptoms and seizure in a case of complicated opioid withdrawal from heroin use.

Ind Psychiatry J
Malik I, Khanra S, Mukherjee A, Munda SK.   +3 more
europepmc   +1 more source

Atypical activation and molecular glue-like dimerization mechanism of an intrinsically-biased chemokine receptor

Banerjee N, Ganguly M, Reyaz A, Mishra S, Dalal A, Guo X, Qiu X, Meyrath M, Palmer CB, Guo H, Song S, Sinha S, Roy N, Mukherjee D, Tiwari D, Yadav MK, Chevigne A, Robinson CV, Chen X, Banerjee R, Shukla AK.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cyclization in Opioid Peptides

Current Drug Targets, 2013
Endogenous opioid peptides have been studied extensively as potential therapeutics for the treatment of pain. The major problems of using natural opioid peptides as drug candidates are their poor receptor specificity, metabolic instability and inability to reach the brain after systemic administration.
Justyna, Piekielna, Renata, Perlikowska, Katarzyna, Gach, Anna, Janecka   +3 more
openaire   +3 more sources